CIA
ALAB icon

Concurrent Investment Advisors’s Astera Labs ALAB Stock Holding History

Concurrent Investment Advisors’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$96.6K Buy
+200
New +$53.1K ﹤0.01% 2027
2025
Q3 		– Sell
-400
Closed -$36.2K – 1615
2025
Q2 		$36.2K Buy
+400
New +$31.6K ﹤0.01% 1357

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Concurrent Investment Advisors's ALAB Position: Q2 2026 in Review

Concurrent Investment Advisors increased its Astera Labs (ALAB) stake by 53% in Q2 2026, buying an estimated $672K and bringing the position to 7,349 shares worth $3.55M. The position accounts for 0.03% of the portfolio, ranked #531.

Concurrent Investment Advisors first reported a position in ALAB in Q2 2025 and has held it in 5 quarters since. 993 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Concurrent Investment Advisors held 7,349 shares of Astera Labs worth $3.55M as of Q2 2026.
  • Concurrent Investment Advisors bought 2,531 Astera Labs shares in Q2 2026, an estimated $672K.
  • Astera Labs made up 0.03% of Concurrent Investment Advisors's portfolio in Q2 2026, its #531 holding.
  • Concurrent Investment Advisors first reported a position in Astera Labs in Q2 2025 and has held it in 5 quarters since.
  • 993 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.